Trials / Completed
CompletedNCT01416480
Clinical Trial to Evaluate the Safety and Efficacy of "Theobromine Capsule" as an Antitussive in Acute Cougher
Therapeutic Confirmatory Clinical Trial to Evaluate the Safety and Efficacy of "Theobromine Capsule 300mg" as an Antitussive Agent in Acute Cough Patients.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 332 (actual)
- Sponsor
- Ahn-Gook Pharmaceuticals Co.,Ltd · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this clinical trial is to evaluate the antitussive effect of "Theobromine capsule 300mg" in patients with acute bronchitis.
Detailed description
This study is double blinded, randomized, parallel designed, phase III clinical trial to evaluate the efficacy and safety of "Theobromine capsule 300mg" versus "Levodropropizine syrup" in patients with acute bronchitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Theobromine 300mg | Capsule, b.i.d. |
| DRUG | Levodropropizine 10mg | Syrup, t.i.d. |
Timeline
- Start date
- 2010-05-01
- Primary completion
- 2011-02-01
- Completion
- 2011-05-01
- First posted
- 2011-08-15
- Last updated
- 2011-08-15
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01416480. Inclusion in this directory is not an endorsement.